![](/img/cover-not-exists.png)
Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy
Labrada, Mayrel, Clavell, Marilyn, Bebelagua, Yanín, León, Joel de, Alonso, Daniel F, Gabri, Mariano R, Veloso, Roberto C, Vérez, Vicente, Fernández, Luis EVolume:
10
Language:
english
Journal:
Expert Opinion on Biological Therapy
DOI:
10.1517/14712590903443084
Date:
February, 2010
File:
PDF, 389 KB
english, 2010